SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

Astrocyte Iron Metabolism and Alpha-Synuclein Pathology in Parkinson's Disease

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-astrocyte-iron-alpha-syn
Related Entities
mechanisms-astrocyte-iron-alpha-synuclein-pathology
Metadata
slugmechanisms-astrocyte-iron-alpha-synuclein-pathology
entity_typemechanism
kg_node_idNone
Linked Artifacts (774)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
mentions🧪Purinergic Signaling Polarization Control70%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%
mentions🧪Mechanosensitive Ion Channel Reprogramming70%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc70%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc70%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc70%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho65%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation65%
related🧪The Glial Ketone Metabolic Shunt Hypothesis65%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho65%
related🧪Adenosine-Astrocyte Metabolic Reset65%
related🧪Lipid Droplet Dynamics as Phenotype Switches65%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue65%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th65%
related🧪Mechanosensitive Ion Channel Reprogramming65%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro65%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes65%
related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste65%
related🧪Extracellular Matrix Stiffness Modulation65%
related🧪APOE Isoform Expression Across Glial Subtypes65%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation65%
related🧪Sphingolipid Metabolism Reprogramming65%
related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted65%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc63%
related🧪Purinergic Signaling Polarization Control63%
related🧪Lipid Droplet Dynamics as Phenotype Switches63%
related🧪Mechanosensitive Ion Channel Reprogramming63%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera60%
related🧫AAV-LRRK2 IND-Enabling Study Design60%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD60%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back60%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio60%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD60%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation60%
related🧫Alpha-Synuclein Seed Amplification Assay Validation60%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation60%
related🧫Antiviral Therapy Trial for Parkinson's Disease60%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&60%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 60%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise60%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 60%
related🧫Combination Therapy Sequencing in Parkinson's Disease60%
related🧫CRISPR Gene Correction Approaches for CBS/PSP60%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa60%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#60%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i60%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#60%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise60%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De60%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD60%
related🧫Ferroptosis Validation in Parkinson's Disease60%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD60%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&60%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me60%
related🧫Cytochrome Therapeutics60%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson60%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown60%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design60%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne60%
related🧫Macroautophagy Dysfunction in PD - Experiment Design60%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P60%
related🧫Validation: Membrane-Nucleation in iPSC Neurons60%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr60%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 60%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag60%
related🧫MLCS Quantification in Parkinson's Disease60%
related🧫Experiment: Multi-Ethnic PD GWAS60%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin60%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'60%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise60%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper60%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 60%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#60%
related🧫Parkinson's Disease Subtype Classification — Precision 60%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea60%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas60%
related🧫Prodromal Parkinson's Disease Biomarker Development — E60%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin60%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson60%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise60%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease60%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D60%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di60%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&60%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki60%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim60%
see_also📖adam1060%
see_also📖ADORA1 Gene60%
see_also📖ABCA1 - ATP-Binding Cassette Transporter A160%
see_also📖ABCG1 Gene60%
see_also📖ABCG4 Gene — ATP-Binding Cassette Subfamily G Member 460%
see_also📖ADNP Gene60%
related🧪The Glial Ketone Metabolic Shunt Hypothesis58%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro58%
related🧪Correcting Gut Microbial Dopamine Imbalance to Support Syste58%
related🧪APOE Isoform Expression Across Glial Subtypes58%
related🧪Nutrient-Sensing Epigenetic Circuit Reactivation58%
related🧪Restoring Neuroprotective Tryptophan Metabolism via Targeted58%
related🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro55%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera54%
related🧫AAV-LRRK2 IND-Enabling Study Design54%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD54%
related🧫Alpha-Synuclein SAA Kinetics Study — Biological Staging Back54%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio54%
related🧫Computational Modeling of Alpha-Synuclein Propagation in PD54%
related🧫Basic Mechanism: Membrane-Driven Alpha-Synuclein Nucleation54%
related🧫Alpha-Synuclein Seed Amplification Assay Validation54%
related🧫Alpha-Synuclein Spreading Mechanism — Prion-Like Propagation54%
related🧫Antiviral Therapy Trial for Parkinson's Disease54%
related🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&54%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 54%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise54%
related🧫Chaperone-Mediated Autophagy Dysfunction in PD - Experiment 54%
related🧫Combination Therapy Sequencing in Parkinson's Disease54%
related🧫CRISPR Gene Correction Approaches for CBS/PSP54%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa54%
related🧫DNA Damage Repair Deficiency Validation Study in Parkinson&#54%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i54%
related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#54%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise54%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De54%
related🧫Exercise-BDNF-Mitophagy Biomarker Study in PD54%
related🧫Ferroptosis Validation in Parkinson's Disease54%
related🧫GLP-1 Agonist Neuroprotection Mechanism in PD54%
related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&54%
related🧫Gut-Brain Axis Pathogenesis in Parkinson's Disease — Me54%
related🧫Cytochrome Therapeutics54%
related🧫Lipid Droplet-Lysosome Axis Therapeutic Testing in Parkinson54%
related🧫Gene Therapy: AAV Serotype Comparison for LRRK2 Knockdown54%
related🧫AAV-LRRK2 Gene Therapy IND-Enabling Study Design54%
related🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne54%
related🧫Macroautophagy Dysfunction in PD - Experiment Design54%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P54%
related🧫Validation: Membrane-Nucleation in iPSC Neurons54%
related🧫Metabolic Syndrome-Parkinson's Disease Axis Clinical Tr54%
related🧫Experiment Design: Metal Ion-Synuclein-Mitochondria Axis in 54%
related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag54%
related🧫MLCS Quantification in Parkinson's Disease54%
related🧫Experiment: Multi-Ethnic PD GWAS54%
related🧫Multiscale Computational Modeling of Protein Aggregation Kin54%
related🧫Neural Oscillation Dysfunction Validation in Parkinson'54%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise54%
related🧫Non-Dopaminergic Neurotransmitter Degeneration in PD - Exper54%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 54%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#54%
related🧫Parkinson's Disease Subtype Classification — Precision 54%
related🧫Peroxisomal Dysfunction Validation in Parkinson's Disea54%
related🧫Peroxisome Dysfunction Validation in Parkinson's Diseas54%
related🧫Prodromal Parkinson's Disease Biomarker Development — E54%
related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin54%
related🧫Purinergic Signaling Dysfunction Validation in Parkinson54%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise54%
related🧫Sirtuin Dysfunction Validation in Parkinson's Disease54%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D54%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di54%
related🧫Synaptic Mitochondrial Resilience Enhancement for Parkinson&54%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki54%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim54%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
mentions🧪Temporal TET2-Mediated Hydroxymethylation Cycling50%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur50%
mentions🧫Proposed experiment from debate on Microglia activate astroc50%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur50%
mentions🧫s:** - ALOX15 overexpression in healthy astrocytes should be50%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be50%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional50%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be50%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/50%
mentions🧫Proposed experiment from debate on Microglia activate astroc50%
mentions🧫Astrocyte Ferritin Iron Metabolism Dysfunction in Parkinson&50%
mentions🧪Temporal Decoupling via Circadian Clock Reset50%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination50%
mentions🧪Oligodendrocyte White Matter Vulnerability50%
mentions🧪Smartphone-Detected Motor Variability Correction50%
mentions🧪Brain Insulin Resistance with Glucose Transporter Dysfunctio50%
mentions🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 50%
mentions🧪Selective HDAC3 Inhibition with Cognitive Enhancement50%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%
mentions🧪CX43 hemichannel engineering enables size-selective mitochon50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪Astrocytic Connexin-43 Upregulation Enhances Neuroprotective50%
mentions🧪APOE-TREM2 Interaction Modulation50%
mentions🧪Senescent Cell Mitochondrial DNA Release50%
mentions🧪SASP-Mediated Cholinergic Synapse Disruption50%
mentions🧪Multi-Modal Stress Response Harmonization50%
mentions🧪RAB27A-dependent extracellular vesicle engineering for mitoc50%
mentions🧪CYP46A1 Overexpression Gene Therapy50%
mentions🧪Epigenetic Memory Reprogramming for Alzheimer's Disease50%
mentions🧪PINK1/Parkin-Independent Mitophagy Bypass for Enhanced Donor50%
mentions🧪Enteric Nervous System Prion-Like Propagation Blockade50%
mentions🧪Age-Dependent Complement C4b Upregulation Drives Synaptic Vu50%
mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%
mentions🧪Retinal Vascular Microcirculation Rescue50%
mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%
mentions🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho50%
mentions🧪Targeted Butyrate Supplementation for Microglial Phenotype M50%
mentions🧪Metabolic Circuit Breaker via Lipid Droplet Modulation50%
mentions🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho50%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors50%
mentions🧪Synthetic Biology Approach: Designer Mitochondrial Export Sy50%
mentions🧪Biorhythmic Interference via Controlled Sleep Oscillations50%
mentions🧪Quantum Coherence Disruption in Cellular Communication50%
mentions🧪The Glial Ketone Metabolic Shunt Hypothesis50%
mentions🧪SIRT6-NAD+ Axis Enhancement Therapy50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪Glycosaminoglycan Template Disruption Approach50%
mentions🧪Circadian Rhythm Entrainment of Reactive Astrocytes50%
mentions🧪SASP-Mediated Complement Cascade Amplification50%
mentions🧪Complement C1q Subtype Switching50%
mentions🧪Proteostasis Enhancement via APOE Chaperone Targeting50%
mentions🧪Microglial Purinergic Reprogramming50%
mentions🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener50%
mentions🧪Glymphatic System-Enhanced Antibody Clearance Reversal50%
mentions🧪Prefrontal sensory gating circuit restoration via PV interne50%
mentions🧪Chaperone-Mediated APOE4 Refolding Enhancement50%
mentions🧪Context-Dependent CRISPR Activation in Specific Neuronal Sub50%
mentions🧪Ocular Immune Privilege Extension50%
mentions🧪GAP43-mediated tunneling nanotube stabilization enhances neu50%
mentions🧪Extracellular Matrix Stiffness Modulation50%
mentions🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
mentions🧪Senescence-Induced Lipid Peroxidation Spreading50%
mentions🧪SASP-Driven Aquaporin-4 Dysregulation50%
mentions🧪Optogenetic Control of Mitochondrial Transfer Networks50%
mentions🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In50%
mentions🧪Circadian-Gated Maresin Biosynthesis Amplification50%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna50%
mentions🧪Blocking AGE-RAGE Signaling in Enteric Glia to Prevent Neuro50%
mentions🧪Astrocyte-Mediated Neuronal Epigenetic Rescue50%
mentions🧪Miro1-Mediated Mitochondrial Trafficking Enhancement Therapy50%
mentions🧪Mitochondrial Transfer Pathway Enhancement50%
mentions🧪TFAM overexpression creates mitochondrial donor-recipient gr50%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%
mentions🧪Pharmacological Enhancement of APOE4 Glycosylation50%
mentions🧪Gap Junction Hemichannel Modulation for Controlled Mitochond50%
mentions🧪Programmable Neuronal Circuit Repair via Epigenetic CRISPR50%
mentions🧪Membrane Cholesterol Gradient Modulators50%
mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%
mentions🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu50%
mentions🧪Flotillin-1 Stabilization Compounds50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%
mentions🧪Enhancing Vagal Cholinergic Signaling to Restore Gut-Brain A50%
mentions🧪Cholesterol-CRISPR Convergence Therapy for Neurodegeneration50%
mentions🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th50%
mentions🧪Chromatin Accessibility Restoration via BRD4 Modulation50%
mentions🧪TREM2-mediated microglial tau clearance enhancement50%
mentions🧪Lysosomal Enzyme Trafficking Correction50%
mentions🧪Circadian Clock-Autophagy Synchronization50%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides50%
mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%
mentions🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai50%
mentions🧪Senescence-Associated Myelin Lipid Remodeling50%
mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%
mentions🧪Glial Glycocalyx Remodeling Therapy50%
mentions🧪Aquaporin-4 Polarization Rescue50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪Senescence-Activated NAD+ Depletion Rescue50%
mentions🧪Competitive APOE4 Domain Stabilization Peptides50%
mentions🧪Epigenetic Memory Erasure via TET2 Activation50%
mentions🧪TET2-Mediated Demethylation Rejuvenation Therapy50%
mentions🧪Microglia-Derived Extracellular Vesicle Engineering for Targ50%
mentions🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)50%
mentions🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme50%
mentions🧪Synthetic Biology Rewiring via Orthogonal Receptors50%
mentions🧪Ephrin-B2/EphB4 Axis Manipulation50%
mentions🧪Vagal Afferent Microbial Signal Modulation50%
mentions🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution50%
mentions🧪Near-infrared light therapy stimulates COX4-dependent mitoch50%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia50%
mentions🧪GFAP-Positive Reactive Astrocyte Subtype Delineation50%
mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%
mentions🧪Excitatory Neuron Vulnerability via SLC17A7 Downregulation50%
mentions🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro50%
mentions🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪Adenosine-Astrocyte Metabolic Reset50%
mentions🧪Sphingolipid Metabolism Reprogramming50%
mentions🧪Gut Barrier Permeability-α-Synuclein Axis Modulation50%
mentions🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬The disease-associated microglia (DAM) phenotype involves TR50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬Is disrupted sleep a cause or consequence of neurodegenerati50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬CRISPR-based therapeutic approaches for neurodegenerative di50%
related🔬Epigenetic reprogramming in aging neurons50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Cell type vulnerability in Alzheimers Disease (SEA-AD transc50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
related🔬How does metabolic reprogramming (glucose metabolism shifts,50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬How to break the GBA-alpha-synuclein bidirectional loop for 50%
related🔬Can gut-brain axis modulation prevent or slow Alzheimer'50%
related🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph50%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration50%
see_also📖Exosomal Biomarkers in Neurodegeneration50%
see_also📖Exosomal miR-155 in Neurodegeneration50%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration50%
see_also📖Liquid Biopsy in Neurodegeneration50%
see_also📖Metabolomic Biomarkers in Neurodegeneration50%
see_also📖Neuroimaging Biomarkers for Neurodegeneration50%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre50%
see_also📖Synaptic Biomarkers in Neurodegeneration50%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and50%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro50%
see_also📖Utilisation of Health Services and Quality of Life in Atypic50%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini50%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 50%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in50%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co50%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St50%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl50%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr50%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime50%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 50%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi50%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc50%
see_also📖China Neurodegeneration Epidemiology50%
see_also📖DALY Methodology — Neurodegeneration50%
see_also📖Disease Progression & Staging in Neurodegeneration50%
see_also📖Economic Burden — Neurodegeneration50%
see_also📖European Neurodegeneration Epidemiology50%
see_also📖Familial vs Sporadic Neurodegeneration Comparison50%
see_also📖Global Neurodegeneration Epidemiology50%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)50%
see_also📖India Neurodegeneration Epidemiology50%
see_also📖Japan Neurodegeneration Epidemiology50%
see_also📖Manganese-Related Neurodegeneration (Manganism)50%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid50%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd50%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison50%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%
see_also📖Potential Impact Measures — Neurodegeneration50%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome50%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)50%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr50%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O50%
see_also📖Sleep Disorders in Neurodegeneration50%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro50%
see_also📖US Neurodegeneration Epidemiology50%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread50%
see_also📖acetylcholine-signaling-neurodegeneration50%
see_also📖Advanced Glycation End Products in Neurodegeneration50%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 50%
see_also📖Amylin Signaling in Neurodegeneration50%
see_also📖Antibody Therapy in Neurodegeneration50%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration50%
see_also📖Autosis Pathway in Neurodegeneration50%
see_also📖Axon Guidance Pathways in Neurodegeneration50%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration50%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for50%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain50%
see_also📖Braak Staging and Tau Propagation Pathway50%
see_also📖CaMKII Signaling Pathway in Neurodegeneration50%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration50%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP50%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology50%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration50%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration50%
see_also📖Cholinergic System Dysfunction in Neurodegeneration50%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat50%
see_also📖Neural Circuits in Neurodegeneration50%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration50%
see_also📖Computational Disease Models for Neurodegeneration50%
see_also📖Convergent Pathways in Neurodegeneration50%
see_also📖Copper Homeostasis in Neurodegeneration50%
see_also📖COVID-19 Neurodegeneration Mechanism50%
see_also📖Diffusion MRI (DTI) in Neurodegeneration50%
see_also📖Digital Phenotyping in Neurodegeneration50%
see_also📖Down Syndrome Neurodegeneration Pathway50%
see_also📖Dystrophic Neurites in Neurodegeneration50%
see_also📖Endocannabinoid System in Neurodegeneration50%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration50%
see_also📖Endosomal Sorting Defects in Neurodegeneration50%
see_also📖Endothelin Signaling Pathway in Neurodegeneration50%
see_also📖epigenetics-neurodegeneration50%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration50%
see_also📖FA2H-Associated Neurodegeneration Pathway50%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%
see_also📖Galectin-3 Mechanism in Neurodegeneration50%
see_also📖Gangliosides in Neurodegeneration50%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration50%
see_also📖GDNF Signaling Pathway in Neurodegeneration50%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t50%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration50%
see_also📖Glial Tau Pathology in PSP and CBD50%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration50%
see_also📖Glycosylation in Neurodegeneration50%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova50%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath50%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration50%
see_also📖Hippocampal Neurogenesis in Neurodegeneration50%
see_also📖Histone Modification Pathways in Neurodegeneration50%
see_also📖HMGB1 Signaling in Neurodegeneration50%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration50%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration50%
see_also📖IL-1 Signaling Pathway in Neurodegeneration50%
see_also📖Integrated Stress Response in Neurodegeneration50%
see_also📖interleukin-6-signaling-neurodegeneration50%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration50%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 50%
see_also📖Kidney-Brain Neurodegeneration Axis50%
see_also📖Lipid Dysregulation in Neurodegeneration50%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration50%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration50%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration50%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration50%
see_also📖Metal Homeostasis in Neurodegeneration50%
see_also📖Microglial Priming Pathway in Neurodegeneration50%
see_also📖MicroRNA Dysfunction in Neurodegeneration50%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration50%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration50%
see_also📖Mitochondrial Fusion in Neurodegeneration50%
see_also📖Molecular Chaperones in Neurodegeneration50%
see_also📖mTOR Signaling in Neurodegeneration50%
see_also📖mTOR Signaling Pathway in Neurodegeneration50%
see_also📖Neural Circuit Disruption in Neurodegeneration50%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N50%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati50%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D50%
see_also📖Neuronal Hyperexcitability in Neurodegeneration50%
see_also📖Neuropil Threads in Neurodegeneration50%
see_also📖Neurotensin Signaling in Neurodegeneration50%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration50%
see_also📖NF-kB Signaling Pathway in Neurodegeneration50%
see_also📖Nitric Oxide Signaling in Neurodegeneration50%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration50%
see_also📖Neuropeptide Y Signaling in Neurodegeneration50%
see_also📖NRF2 Signaling Pathway in Neurodegeneration50%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration50%
see_also📖Orexin Signaling in Neurodegeneration50%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration50%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration50%
see_also📖Paranodal Dysfunction in Neurodegeneration50%
see_also📖Paraptosis in Neurodegeneration50%
see_also📖Parthanatos in Neurodegeneration50%
see_also📖Pericyte Loss in Neurodegeneration50%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%
see_also📖PKR Pathway in Neurodegeneration50%
see_also📖PPAR Signaling Pathway in Neurodegeneration50%
see_also📖Prion Diseases in Neurodegeneration50%
see_also📖Prion-Like Spread in Neurodegeneration50%
see_also📖Prion Protein Metabolism in Neurodegeneration50%
see_also📖Progesterone Signaling Pathway in Neurodegeneration50%
see_also📖Prognostic Biomarkers in Neurodegeneration50%
see_also📖Protein Aggregation Comparison in Neurodegeneration50%
see_also📖Protein Aggregation Seeds in Neurodegeneration50%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration50%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su50%
see_also📖Purinergic Signaling in Neurodegeneration50%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener50%
see_also📖R-Loop Stress in Neurodegeneration50%
see_also📖RAN Translation in Neurodegeneration50%
see_also📖Retinal Degeneration Pathway in Neurodegeneration50%
see_also📖Ribosome Dysfunction in Neurodegeneration50%
see_also📖RNA Splicing in Neurodegeneration50%
see_also📖RNA-Targeted Therapies in Neurodegeneration50%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a50%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration50%
see_also📖Senescent Cell Clearance in Neurodegeneration50%
see_also📖Serotonergic Dysfunction in Neurodegeneration50%
see_also📖Sex Differences in Neurodegeneration50%
see_also📖Short Chain Fatty Acids in Neurodegeneration50%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration50%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%
see_also📖Sleep Dysfunction in Neurodegeneration50%
see_also📖SUMOylation in Neurodegeneration50%
see_also📖synaptic-vesicle-cycling-neurodegeneration50%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration50%
see_also📖Systemic Infection and Tau Pathology Acceleration50%
see_also📖T-Cell Dysfunction in Neurodegeneration50%
see_also📖Tau Seeding and Propagation Pathway50%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration50%
see_also📖Therapeutic Targets in Neurodegeneration50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration50%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration50%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration50%
see_also📖Vagus Nerve Pathway in Neurodegeneration50%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio50%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio50%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen50%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration50%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality50%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖alexander-disease45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Investment Landscape: ALS45%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Investment Landscape: Huntington's Disease45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Sandhoff Disease45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖SNCA Gene Variants and Mutations45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖APOE4 and Alzheimer's Disease Risk45%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖Synaptic Loss and Dysfunction Pathway45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
mentions🧫Tet2 modulation in Aβ42-injured mouse hippocampal neurons44%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio44%
mentions🧫Epigenetic Clocks in Neurodegeneration — Causal Drivers or P44%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬How to break the GBA-alpha-synuclein bidirectional loop for 40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬Is disrupted sleep a cause or consequence of neurodegenerati40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬Can gut-brain axis modulation prevent or slow Alzheimer'40%
mentions🔬Astrocytes adopt A1 (neurotoxic) and A2 (neuroprotective) ph40%
mentions🔬What are the mechanisms underlying selective vulnerability o40%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying neuroinflammation resolut40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
mentions🔬What are the mechanisms underlying rna binding protein dysre40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬What are the mechanisms underlying perivascular spaces and g40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
mentions🔬Investigate how lipid raft composition (cholesterol metaboli40%
mentions🔬How does metabolic reprogramming (glucose metabolism shifts,40%
mentions🔬Investigate prion-like spreading of tau pathology through co40%
related🧪ACSL4-Driven Ferroptotic Priming in Disease-Associated Micro40%
related🧪Astrocyte MCT1/MCT4 Ratio Disruption with Metabolic Uncoupli40%
related🧪SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK40%
related🧪Temporal Decoupling via Circadian Clock Reset40%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination40%
related🧪Smartphone-Detected Motor Variability Correction40%
related🧪Osmotic Gradient Restoration via Selective AQP1 Enhancement 40%
related🧪Selective HDAC3 Inhibition with Cognitive Enhancement40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer40%
related🧪CX43 hemichannel engineering enables size-selective mitochon40%
related🧪Senescent Cell Mitochondrial DNA Release40%
related🧪SASP-Mediated Cholinergic Synapse Disruption40%
related🧪Multi-Modal Stress Response Harmonization40%
related🧪RAB27A-dependent extracellular vesicle engineering for mitoc40%
related🧪CYP46A1 Overexpression Gene Therapy40%
related🧪Enteric Nervous System Prion-Like Propagation Blockade40%
related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%
related🧪Retinal Vascular Microcirculation Rescue40%
related🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition40%
related🧪Astroglial Gap Junction Coordination via Connexin-43 Phospho40%
related🧪Metabolic Circuit Breaker via Lipid Droplet Modulation40%
related🧪Adenosine-Astrocyte Metabolic Reset40%
related🧪AMPK hypersensitivity in astrocytes creates enhanced mitocho40%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones40%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors40%
related🧪Biorhythmic Interference via Controlled Sleep Oscillations40%
related🧪Quantum Coherence Disruption in Cellular Communication40%
related🧪SIRT6-NAD+ Axis Enhancement Therapy40%
related🧪Circadian Rhythm Entrainment of Reactive Astrocytes40%
related🧪SASP-Mediated Complement Cascade Amplification40%
related🧪Complement C1q Subtype Switching40%
related🧪Microglial Purinergic Reprogramming40%
related🧪Astrocytic Lactate Shuttle Enhancement for Grid Cell Bioener40%
related🧪Glymphatic System-Enhanced Antibody Clearance Reversal40%
related🧪Prefrontal sensory gating circuit restoration via PV interne40%
related🧪Chaperone-Mediated APOE4 Refolding Enhancement40%
related🧪Sphingolipid Metabolism Reprogramming40%
related🧪Ocular Immune Privilege Extension40%
related🧪Gut Barrier Permeability-α-Synuclein Axis Modulation40%
related🧪GAP43-mediated tunneling nanotube stabilization enhances neu40%
related🧪Extracellular Matrix Stiffness Modulation40%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism40%
related🧪Microbial Metabolite-Mediated α-Synuclein Disaggregation40%
related🧪Senescence-Induced Lipid Peroxidation Spreading40%
related🧪SASP-Driven Aquaporin-4 Dysregulation40%
related🧪Matrix Stiffness Normalization via Targeted Lysyl Oxidase In40%
related🧪Circadian-Gated Maresin Biosynthesis Amplification40%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna40%
related🧪Astrocyte-Mediated Neuronal Epigenetic Rescue40%
related🧪Mitochondrial Transfer Pathway Enhancement40%
related🧪TFAM overexpression creates mitochondrial donor-recipient gr40%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction40%
related🧪Pharmacological Enhancement of APOE4 Glycosylation40%
related🧪Membrane Cholesterol Gradient Modulators40%
related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%
related🧪Aquaporin-4 Polarization Enhancement via TREK-1 Channel Modu40%
related🧪Flotillin-1 Stabilization Compounds40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy40%
related🧪Astrocytic Lipoxin A4 Pathway Restoration via ALOX15 Gene Th40%
related🧪Chromatin Accessibility Restoration via BRD4 Modulation40%
related🧪TREM2-mediated microglial tau clearance enhancement40%
related🧪Lysosomal Enzyme Trafficking Correction40%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides40%
related🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri40%
related🧪Partial Neuronal Reprogramming via Modified Yamanaka Cocktai40%
related🧪Senescence-Associated Myelin Lipid Remodeling40%
related🧪Gamma entrainment therapy to restore hippocampal-cortical sy40%
related🧪Glial Glycocalyx Remodeling Therapy40%
related🧪Aquaporin-4 Polarization Rescue40%
related🧪Senescence-Activated NAD+ Depletion Rescue40%
related🧪Competitive APOE4 Domain Stabilization Peptides40%
related🧪Epigenetic Memory Erasure via TET2 Activation40%
related🧪TET2-Mediated Demethylation Rejuvenation Therapy40%
related🧪Circadian Glymphatic Rescue Therapy (Melatonin-focused)40%
related🧪Tau-Independent Microtubule Stabilization via MAP6 Enhanceme40%
related🧪Synthetic Biology Rewiring via Orthogonal Receptors40%
related🧪Ephrin-B2/EphB4 Axis Manipulation40%
related🧪Vagal Afferent Microbial Signal Modulation40%
related🧪Oligodendrocyte Protectin D1 Mimetic for Myelin Resolution40%
related🧪Near-infrared light therapy stimulates COX4-dependent mitoch40%
mentions🔬Analyze circuit-level changes in neurodegeneration using All35%
mentions🔬CRISPR-based therapeutic approaches for neurodegenerative di35%
mentions🔬Epigenetic reprogramming in aging neurons35%
mentions🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas35%
related🧪GFAP-Positive Reactive Astrocyte Subtype Delineation35%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub